Crossmark

An adenosine derivative for the treatment of hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1038/s41568-026-00945-9

Published Online: 2026-05-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Díaz-Muñoz, Mauricio https://orcid.org/0000-0002-9019-8246
License Information

Text and Data Mining valid from 2026-05-29

Version of Record valid from 2026-05-29
More Information

Article History

First Online: 29 May 2026

Competing interests

: The author declares no competing interests.